极化特异性巨细胞衍生的细胞外囊泡:分子载荷,瘤微环境重塑和治疗机会
Xudong Liu1, Yan Yang2, Lu Ren3
1College of Basic Medicine, Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, People's Republic of China.
International journal of nanomedicine
|March 11, 2026
概括
巨细胞衍生的细胞外囊泡 (EVs) 作为关键的信息载体,M1-EVs抑制瘤,M2-EVs促进癌症的进展. 了解它们的载荷和功能为癌症治疗提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 巨细胞衍生的细胞外囊泡 (EVs) 是瘤进展的关键调节者.
- 这些EV反映了巨细胞极化状态,并积极重编程瘤微环境.
- 它们作为信息中心,将巨细胞激活与瘤细胞和免疫细胞表型联系起来.
研究的目的:
- 为癌症中巨细胞衍生的EVs提出一个概念框架.
- 总结电动汽车中偏振取决于货物选择的机制.
- 要突出巨细胞衍生的EVs在癌症诊断和治疗中的翻译含义.
主要方法:
- 对巨细胞衍生的EVs的文献进行系统审查.
- 基于巨细胞极化 (M1与M2) 的EV货物 (非编码RNA,蛋白质) 的分析.
- 讨论电动汽车生物发生,货物分类和转化策略.
主要成果:
- 来自M1巨细胞的EVs提供瘤抑制信号,抑制扩散,入侵和免疫逃避.
- 源自M2巨细胞的EVs通过驱动上皮细胞-介质细胞过渡,代谢重编程和免疫抑制来促进瘤的进展.
- 机制包括RNA结合蛋白质介导分类,代谢控制和EV生物发生调节.
结论:
- 巨细胞衍生的EVs是瘤行为的偏振依赖的效应因子.
- M1 EVs提供抗瘤潜力,而M2 EVs驱动瘤发生.
- 电动汽车代表了精确的癌症治疗和诊断的可操作的目标和工具.
更多相关视频
相关概念视频
The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
The Tumor Microenvironment
3.0K
3.0K
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Overview of Exosomes
3.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.8K


